The Pharmacy Vigilance Center affiliated to the Egyptian Medicines Authority emphasized the danger of improper use of the preparations without medical supervision and supervision, stressing that in light of the continuous follow-up and coordination with the international bodies and bodies concerned with pharmaceutical preparations and public health, and regarding news circulating about the use of medicines containing hydrochloroquine in treating a virus Corona emerging COVID-19 The center clarifies the following:
– Preparations containing the hydroxychloroquine compound registered in the Arab Republic of Egypt and abroad, and it is currently authorized to treat malaria, lupus and rheumatoid arthritis.
– According to the bulletins approved by the international health bodies and regulatory authorities for hydroxychloroquine, this compound has many adverse effects, including the negative impact on the heart muscle and retinal damage, and the product has many interactions with other drugs, including sugar and some heart drugs Therefore, these compounds should not be used without medical guidance and supervision to ensure the safe use of the preparation and to avoid any risks or adverse effects.
– Do not use preparations containing the hydroxychloroquine compound except after approval of its use through a specific treatment protocol and hospitals specializing in treating patients with corona and under medical guidance and supervision.
– The necessity to follow the instructions of the Ministry of Health and Population regarding sterilization and prevention of HIV infection COVID-19.
The Egyptian Medicines Authority added that it is following up with all the scientific departments and health control authorities in this regard and that, according to the information available so far, the studies that have been carried out on these preparations have been made on small numbers of patients and need further study, and that all instructions issued so far stressed that The use of hydroxychloroquine with some antibiotics must be under medical supervision and in hospitals only, with great caution in the possibility of drug interactions.
The Egyptian Medicines Authority confirms that it is constantly following up with the relevant regulatory bodies and authorities, the Ministry of Health and Population, research centers and specialized scientific committees to verify the effectiveness of the hydroxychloroquine complex in treating simple and medium cases of COVID-19 To reduce the duration of symptoms and get rid of the virus, studies are underway to determine the effectiveness of use in treatment COVID-19, As the US Food and Drug Administration explained FDA On (3/19/2020) that until now no drug has been approved for the treatment or prevention against the Coronavirus.
– .
